Alpha Tau Medical Ltd
DRTS
View Detailed Chart
3.810USD
-0.030-0.78%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
268.15MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.78%
5 Days
-0.52%
1 Month
+16.87%
6 Months
+45.70%
Year to Date
+22.90%
1 Year
+63.52%
View Detailed Chart
TradingKey Stock Score
Currency: USD Updated：2025-09-17Key Insights
Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Strong Buy. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Score
Support & Resistance
No Data
Score Analysis
Current score
Previous score
Analyst Rating
Based on
4
analysts
Strong Buy
Current Rating
8.500
Target Price
+120.20%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Company Highlights
StrengthsRisks
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.
Undervalued
The company’s latest PE is -7.95, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 29.36M shares, increasing 32.33% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 29.40K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.42.
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.
Ticker SymbolDRTS
CompanyAlpha Tau Medical Ltd
CEOMr. Uzi Sofer
Websitehttps://www.alphatau.com/
Related Instruments
+1.79%
+0.50%
-0.27%
+1.21%
+1.64%
-0.86%
+0.58%
+0.71%
-3.43%
+1.25%
+0.89%
+2.14%
+0.10%
+2.78%
+2.44%
+3.61%
+1.08%
+1.33%
+1.42%
+3.52%
